why choose us

First received: May 09, 2023

Clinical Trial: A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-blind, Sponsor-Open, Placebo- and Positive-Controlled Crossover Study to Investigate the Effect of Multiple Doses of Sisunatovir on QTc Interval in Healthy Adult Particip

Brief Summary: The purpose of the study is to investigate the effects of multiple oral doses of sisunatovir on QTc Interval.This study is seeking participants who:are male or female of 18 years of age or olderare examined to be healthy All participants will receive Treatment A, B, and C in a randomized order based on 6 possible sequences.All treatments will be taken by mouth.Participants assigned to treatment A will receive 5 oral doses of sisunatovir administered Q12 hours over 3 days in a fed state.Participants assigned to…

Read more